WebBiomarkers remain urgently needed as tools for differential diagnosis, prognosis and disease progression, and as therapeutic response predictors in SSc-ILD. Although ANA were the first biomarkers available in SSc, they still are unhelpful for the assessment of disease activity and treatment response [9, 10]. ... CCL2 + + NK Higher serum levels ... WebDec 18, 2024 · CCL2, also known as monocyte chemoattractant protein-1, is a small cytokine belonging to the CC chemokine family. Cytokines are substances, such as interferon, interleukin and growth factors, secreted …
Postoperative elevation in the plasma CCL2 level is a predictive ...
WebJan 30, 2012 · The chemokine C-C motif ligand 2 (CCL2; also called monocyte chemotactic protein-1 (MCP-1)), which is produced by neurons and glial cells, activates the CCR2-receptor and can induce chemotaxis of monocytes and microglia, contributing to pathological microgliosis [7], [8]. WebJan 4, 2024 · It was significantly associated with poor prognosis and immune cell infiltration. Thus, SPP1 may become a promising prognostic biomarker for cervical cancer patients. 1 Introduction Cervical cancer remains the fourth most common cancer among women and accounts for 527,624 new diagnosed cases and 265,672 deaths in 2024 ( Bray et al. … quitting it\\u0027s like trying but easier
Serum CCL2 and CCL3 as potential biomarkers for the ... - Springer
WebAug 2, 2024 · In this review, we discuss recent advances in signaling of platelet activation-related biomarkers in inflammatory settings and application prospects to apply for disease diagnosis and treatment. Introduction Platelets were first reported to be involved in hemostasis, thrombosis and wound healing. WebMar 21, 2024 · Cincinnati Children's Hospital Medical Center. Sep 2009 - Aug 20145 years. - Investigated the mechanisms linking hemostatic … WebJul 25, 2014 · Diagnostic significance of CCL2–CCL3 in OSCC patients An ROC analysis implicated that CCL2 was a diagnostic biomarker to discriminate OSCC patients from healthy people (AUC = 0.920, P < 0.0001), and the optimal value of CCL2 for stratifying OSCC patients to healthy people is 101.1 pg/ml (Fig. 3a ). quitting is good